Female genital injury-which findings have to be considered physiological using colposcopy with and without toluidine blue dye? - Berlit C, S ütterlin M, Yen K, Weiß C, Heinze S, Tuschy B, Berlit S.
This study aimed to assess the validity and efficacy of blue dye in colposcopic assessment of genital injury in pre- and postmenopausal women with and without history of consensual sexual intercourse. Two hundred women were prospectively enrolled and exami... (Source: SafetyLit)
Source: SafetyLit - October 11, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

OOP costs common for colposcopy in commercially insured US women
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - October 1, 2021 Category: Drugs & Pharmacology Source Type: news

American Society for Colposcopy and Cervical Pathology discusses updated American Cancer Society guidelines on cervical cancer screening
(Wolters Kluwer Health) Last year, the American Cancer Society (ACS) issued an updated set of guidelines for cervical cancer screening - emphasizing the shift toward screening with primary human papillomavirus (HPV) testing. While the ACS recommendation accounts for a transition period to implement primary HPV screening, additional factors should be considered to operationalize these guidelines, according to a special white paper in the July issue of the Journal of Lower Genital Tract Disease (JLGTD), official journal of ASCCP. The journal is published in the Lippincott portfolio by Wolters Kluwer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 23, 2021 Category: Cancer & Oncology Source Type: news

Colposcopic genital findings in female sexual assault victims: relationship to prior sexual intercourse experience - Rossman L, Solis S, Ouellette L, Kolacki C, Jones JS.
There is scant literature addressing genital injuries in sexually assaulted women who had no prior sexual intercourse experience at the time of the assault. Prior studies in adolescent patients suggest that young women without prior sexual intercourse suff... (Source: SafetyLit)
Source: SafetyLit - November 13, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

How Painful Is Colposcopy?
Title: How Painful Is Colposcopy?Category: Diseases and ConditionsCreated: 11/5/2020 12:00:00 AMLast Editorial Review: 11/5/2020 12:00:00 AM (Source: MedicineNet Womens Health General)
Source: MedicineNet Womens Health General - November 5, 2020 Category: OBGYN Source Type: news

Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Basel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec®PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions about which women will benefit most from immediate follow-up. Laboratories can now use CINtecPLUS Cytology to triage positive results from the cobas ® HPV Test run on the fully integrated, automated and high-throughput co...
Source: Roche Investor Update - September 16, 2020 Category: Pharmaceuticals Source Type: news

Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Basel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec®PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions about which women will benefit most from immediate follow-up. Laboratories can now use CINtecPLUS Cytology to triage positive results from the cobas ® HPV Test run on the fully integrated, automated and high-throughput co...
Source: Roche Media News - September 16, 2020 Category: Pharmaceuticals Source Type: news

Artificial Intelligence Provides Benefit for Cervical Cancer Screening
Automated dual - stained slide evaluation reduces number of colposcopies versus current standards (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 1, 2020 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Infections, Internal Medicine, Oncology, Pathology, Journal, Source Type: news

Artificial Intelligence Provides Benefit for Cervical Cancer Screening
WEDNESDAY, July 1, 2020 -- For women undergoing human papillomavirus (HPV)-based cervical cancer screening, automated evaluation of p16/Ki-67 dual-stained (DS) slides reduces the number of colposcopies compared with current standards, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 1, 2020 Category: Pharmaceuticals Source Type: news

Roche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer
             Basel, 21 April 2020 - Roche (SIX: RO, ROG; OTCQX:RHHBY) today announced US Food and Drug Administration (FDA) approval for the cobas ® HPV test for use on the fully automated, high-throughput cobas® 6800/8800 Systems. The cobas® HPV test identifies women at risk for cervical cancer by detecting the presence of high-risk human papillomavirus (HPV) DNA in cervical samples. Persistent high-risk HPV infections can develop into pre cancerous lesions and, if left untreated, these lesions can progress to cervical cancer.“The approval of our HPV test for the cobas 6800 and 8800 Systems enables molec...
Source: Roche Media News - April 21, 2020 Category: Pharmaceuticals Source Type: news

Roche receives FDA approval for CINtec PLUS Cytology test to aid clinicians in improving cervical cancer prevention
Basel, 11 March 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) approval of CINtec®PLUS Cytology as the first biomarker-based triage test for women whose primary cervical cancer screening results are positive for the human papillomavirus (HPV) using the cobas ® 4800 HPV Test. This biomarker technology simplifies clinical decision making by providing easy to understand results so that clinicians and women are clear on next steps. The CINtecPLUS Cytology test identifies those women whose HPV infections are most likely to be associated with cervical pre-cancers. It enables c...
Source: Roche Media News - March 11, 2020 Category: Pharmaceuticals Source Type: news

MobileODT touts colposcope-based cervical cancer detection AI
MobileODT said last week that it is implementing a new artificial intelligence algorithm in its EVA system Colposcope that it claims can detect cervical cancer more effectively than existing testing. The new technology, known as Automated Visual Evaluation, has been validated by the National Cancer Institute and the National Library of Medicine, the Israel-based company said, and is able to identify problematic lesions with greater reliability than traditional Pap Cytology testing. MobileODT said that it is working with the NCI and other researchers to continue validating the AVE algorithm, and that it is launching a larg...
Source: Mass Device - January 15, 2019 Category: Medical Devices Authors: Fink Densford Tags: Imaging Software / IT Women's Health mobileodt Source Type: news

Dysis Medical raises $25m
Dysis Medical said yesterday it raised $25 million (GBP £18 million) in a new round to help support its Dysis colposcope used for cervical cancer screenings. The Dysis colposcope uses both optical imaging and software to scan the cervix to improve cervical cancer screening procedures, the company said. Funds in the round will help support expansion into the US, across the U.K. and in “other key territories,” the Edinburgh, Scotland-based company said. Funds may also be used to support strategic R&D. “We are excited to support the rapid growth of Dysis Medical and the advancement of the Dysis colposco...
Source: Mass Device - July 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Oncology Women's Health DySIS Medical Source Type: news

Cytology versus HPV testing for cervical cancer screening in the general population: a DTA Review from the Cochrane Gynaecological, Neuro-oncology and Orphan Cancers Group, (CGNOC)
Cochrane Reviews are systematic reviews of research in health care and policy. They are internationally recognized as a high-quality source of evidence for decision-making. They collate and summarize all the best available research evidence on the effects of healthcare interventions or the accuracy of diagnostic tests into a systematic review.Diagnostic Test Accuracy Reviews (DTA) provide essential information regarding the accuracy of the available diagnostic tools for key decision makers, including patients, clinicians, guideline developers and researchers.  The purpose of a Cochrane DTA review is very like the purpose ...
Source: Cochrane News and Events - August 14, 2017 Category: Information Technology Authors: mumoquit at cochrane.org Source Type: news

Physicians evaluate new device to test for cervical cancer
(University of California - Riverside) When a woman has an abnormal pap smear she usually undergoes colposcopy. Typically a metal instrument is used to obtain a small sampling of cells inside the cervix--an oftentimes painful procedure for the patient. A clinical faculty member in the UC Riverside School of Medicine and colleagues have tested an alternative device called fabric-based endocervical curettage. This less painful device had significantly fewer 'inadequate' specimens--meaning, patients didn't need to return for repeat biopsies. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - August 2, 2017 Category: International Medicine & Public Health Source Type: news